SCHEMBL1848238

SCHEMBL1848238

COc1ccc(-c2cc3ccc(C(N)=O)cn3c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 2/20 0.55
▸ PARP10 Q53GL7 2/20 0.54
▸ PARP1 P09874 2/20 0.54
▸ CA1 P00915 1/20 0.54
▸ CA2 P00918 1/20 0.54
▸ PARP2 Q9UGN5 1/20 0.54
▸ PARP4 Q9UKK3 1/20 0.54
▸ MAPKAPK2 P49137 3/20 0.51
▸ CHEK2 O96017 3/20 0.51
▸ MKNK1 Q9BUB5 1/20 0.48
▸ MKNK2 Q9HBH9 1/20 0.48
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ RXRA P19793 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ BRD4 O60885 1/20 0.42
▸ BRD9 Q9H8M2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7442028 0.78 PARP10 (0.88) MAP4K4PARP10PARP1CA1CA2
SCHEMBL14864456 0.75 DHODH (0.51) PARP10PARP1BRD4BRD9
SCHEMBL28188209 0.74 RXRA (0.71) MAP4K4PARP10PARP1CA1CA2
SCHEMBL201761 0.73 PARP10 (1.00) MAP4K4PARP10PARP1CA1CA2
SCHEMBL3896372 0.71 ALDH1A3 (0.47) NPC1RAB9AKDM4EALDH1A1POLB
Hydrochloric Acid SCHEMBL4376056 0.71 PARP10 (0.95) MAP4K4PARP10PARP1CA1CA2
Hydrochloric Acid SCHEMBL408766 0.71 PARP10 (0.95) MAP4K4PARP10PARP1CA1CA2
SCHEMBL13412869 0.70 NR4A2 (0.36) PARP10PARP1CHEK2MKNK1MKNK2
SCHEMBL1847594 0.70 RAB9A (0.61) NPC1RAB9AKDM4EALDH1A1POLB
SCHEMBL3720494 0.70 PARP1 (0.67) MAP4K4PARP10PARP1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 — — US disclosed
EP-2323697-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY Siemens Medical Solutions USA, Inc. (US) 2011-05-25 — — EP disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 — — US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB MAP4K4 4649/4885PARP10 874/4885PARP1 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback